This "promising first step" could help to treat bladder, oral, head and neck tumors more effectively, said biomedical ...

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

A recent study reveals low rates of upper tract urothelial carcinoma in non-muscle-invasive bladder cancer, prompting a ...

Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.

Treatment with Zusduri had a median duration of response of 3.5 years and event-free survival of two years in low-grade ...

The Global Bladder Cancer Market was valued at USD 4.4 Billion in 2024, and it is expected to reach USD 7.2 Billion by 2035, ...

Bladder cancer is seen as a condition that gives off loud warning bells, blood in urine, painful urination, and sudden weight ...

Dr. Kobashi says that the most common symptom of bladder cancer is blood in urine. The blood can range from bright red to a rusty brown color and can make urine appear more brown than yellow. Or, it ...

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

AstraZeneca receives CDSCO approval for Durvalumab, a new treatment for muscle-invasive bladder cancer in India. This marks a ...